Rayscape (formerly XVision) is a medtech platform assisting radiologists in analyzing chest medical imaging with AI, highlighting abnormalities, prioritizing studies by urgency, and generating structured reports to support radiologists, oncologists, and hospital IT teams.
Rayscape CXR identifies over 148 pathologies on chest X-rays, including lung cancer, pneumonia, and tuberculosis. Rayscape Lung CT detects, measures, and tracks pulmonary nodules ranging from 3 to 30mm in diameter, with subtracted and bone-suppressed image generation enhancing visualization of soft tissue. The platform is backed by multiple FDA clearances, extensive clinical validation, and a training database of over 42 million medical images.
Rayscape targets radiologists, oncologists, and hospital IT departments integrating AI-assisted imaging analysis into clinical workflows, with a public web demo available and a listing on the independent Health AI Register. Specific commercial pricing isn’t disclosed on the pages reviewed; it’s sold through direct engagement with healthcare institutions.
